At the MTF level, the CCEP record should include all CCEP forms and relevant medical data to the program.
Blank forms included with this guide supersede previous editions of these forms and are intended to be used with the new CCEP.
All individual forms will be complete and legible.
Forms forwarded to NMIMC and maintained in the participant record shall be in the following order:
MTF Phase I Diagnosis Form
Provider-Administered Symptom Questionnaire
Information Release Form
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 127
--> Appendix H Outline of the CCEP Medical Protocol FORM REQUIREMENTS At the MTF level, the CCEP record should include all CCEP forms and relevant medical data to the program. Blank forms included with this guide supersede previous editions of these forms and are intended to be used with the new CCEP. All individual forms will be complete and legible. Forms forwarded to NMIMC and maintained in the participant record shall be in the following order: Phase I completed: MTF Phase I Diagnosis Form Patient Questionnaire Provider-Administered Symptom Questionnaire Information Release Form Declination/Completion Form
OCR for page 127
--> Phase II completed: RMC Phase II Diagnosis Form Declination/Completion Form MEDICAL PROTOCOLS The CCEP is based upon a thorough clinical evaluation which emphasizes comprehensive and continuous primary care. The local MTF primary care provider maintains responsibility for patient evaluation and care throughout the CCEP process. Medical Treatment Facility (Phase I) Phase I will consist of a comprehensive history and medical evaluation with completion of Phase I questionnaires and related forms. The examination, both in content and quality, should parallel an inpatient admission work-up. The Phase I examination will include a complete medical history including: family, occupation, social (including tobacco, alcohol, and drug use), exposure to possible toxic agents, psychosocial condition and review of symptoms. The provider will specifically inquire about the symptoms listed on the CCEP Provider-Administered Patient Questionnaire. A comprehensive medical evaluation, with focused attention to the patients' symptoms and health concerns, should be conducted. Individuals who, after completing MTF Phase I evaluations, do not have a clearly defined diagnosis which explains their symptoms should be reviewed by the CCEP-designated physician for further evaluation and consultations needed and/or for referral to the RMC. Phase II level evaluations are performed only after complete clinically indicated evaluations (including appropriate specialty consultations) are conducted at the MTF and the RMC. Phase I Laboratory Tests CBC U/A SMA-12
OCR for page 127
--> Regional Medical Center (Phase II) Phase II evaluations consist of the following laboratory tests, consultations, and as necessary, symptom-specific examinations. Elements of the Phase II evaluation may be accomplished by the local MTF as needed in the comprehensive evaluation of the Phase I patient in order to obtain a definitive diagnosis. Phase II Laboratory Tests CBC Sedimentation rate (ESR) C-Reactive protein Rheumatoid factor B12 and folate ANA Thyroid function tests Liver function CPK Urinalysis TB skin test (PPD) with controls Chest X-ray Hepatitis serology HIV testing VDRL B12 and folate Thyroid function tests Phase II Consults (if not accomplished at MTF level) Dental: Dental only if participant's annual screening not done Infectious disease Psychiatry: With physician-administered instruments: Structured Clinical Interview for DSMIII-R (SCID) (delete modules for mania and psychosis) Clinician-Administered PTSD Scale (CAPS) Neuropsychological Testing: Only as indicated by psychiatry consult SYMPTOM-SPECIFIC EXAMINATIONS The RMC CCEP physician ensures that Phase II patients with the following undiagnosed symptoms receive the tests and consultations listed below.
OCR for page 127
--> Diarrhea Abdominal Headache GI consult Stool for O and P Stool leukocytes Stool culture Stool culture Stool volume Colonscopy with biopsies EGD with biopsies and aspiration Muscle Aches/ Numbness EMG/NCV Chronic Fatigue Polysomnography and MSLT Chronic Cough/SOB Pulmonary consult Pulmonary function Tests with exercise and ABG Methacholine challenge If PFTs are normal, consider broncho scopy with biopsy/ lavage GI consult EGD with biopsy/ aspiration Colonscopy with biopsy Abdominal ultrasound UGI series with small bowel FT Abdominal CT scan Memory Loss (Only if verified by psych evaluation) MRI-head Lumbar puncture Neuro consult Neuro psych testing Chest Pain/ Palpitations ECG Exercise stress test Holter monitor MRI-head LP (glucose protein, cell count, VDRL, oligoclonal myelin, basic protein, pressure) Neuro consult Vertigo/Tinnitus Audiogram ENG BAER Skin Rash Dermatology consult Consider biopsy Reproductive Concerns Urology consult GYN consult